Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
ClH/c9-13(11
the COX2 induction is reduced[4]
Administration of Temsirolimus induces significant dose-dependent
such as NODI and NOD2
CAS Number: 909089-13-0
Sunitinib - CAS# 557795-19-4 Size:Solid 10 mg ClH/c9-13(11Sunitinib free base is an oral, small molecule, multi targeted receptor tyrosine kinase (RTK) inhibitor. Sunitinib malate salt was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib inhibits cellular signaling by targeting multiple receptor tyrosine kinases (RTKs). The simultaneous inhibition of these targets therefore reduces tumor